Literature DB >> 21741878

Mucosal biofilms of Candida albicans.

Shantanu Ganguly1, Aaron P Mitchell.   

Abstract

Biofilms are microbial communities that form on surfaces and are embedded in an extracellular matrix. C. albicans forms pathogenic mucosal biofilms that are evoked by changes in host immunity or mucosal ecology. Mucosal surfaces are inhabited by many microbial species; hence these biofilms are polymicrobial. Several recent studies have applied paradigms of biofilm analysis to study mucosal C. albicans infections. These studies reveal that the Bcr1 transcription factor is a master regulator of C. albicans biofilm formation under diverse conditions, though the most relevant Bcr1 target genes can vary with the biofilm niche. An important determinant of mucosal biofilm formation is the interaction with host defenses. Finally, studies of interactions between bacterial species and C. albicans provide insight into the communication mechanisms that endow polymicrobial biofilms with unique properties.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741878      PMCID: PMC3159763          DOI: 10.1016/j.mib.2011.06.001

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  58 in total

Review 1.  Persister cells.

Authors:  Kim Lewis
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 2.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

3.  Adaptations of Candida albicans for growth in the mammalian intestinal tract.

Authors:  Ari Rosenbach; Daniel Dignard; Jessica V Pierce; Malcolm Whiteway; Carol A Kumamoto
Journal:  Eukaryot Cell       Date:  2010-04-30

Review 4.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

5.  Development and validation of an in vivo Candida albicans biofilm denture model.

Authors:  Jeniel E Nett; Karen Marchillo; Carol A Spiegel; David R Andes
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

6.  Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

Authors:  Guanpingsheng Luo; Ashraf S Ibrahim; Brad Spellberg; Clarissa J Nobile; Aaron P Mitchell; Yue Fu
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

Review 7.  Pathogenesis of invasive candidiasis.

Authors:  Frank L van de Veerdonk; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Opin Crit Care       Date:  2010-10       Impact factor: 3.687

8.  Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines.

Authors:  Raouf Bahri; Sèverine Curt; Dalila Saidane-Mosbahi; Mahmoud Rouabhia
Journal:  Mediators Inflamm       Date:  2010-05-03       Impact factor: 4.711

9.  Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Mark A Scheper; Jeff G Leid; John William Costerton; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-06-07

10.  A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells.

Authors:  David L Moyes; Manohursingh Runglall; Celia Murciano; Chengguo Shen; Deepa Nayar; Selvam Thavaraj; Arinder Kohli; Ayesha Islam; Hector Mora-Montes; Stephen J Challacombe; Julian R Naglik
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

View more
  63 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 2.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  Role of phosphatidylinositol phosphate signaling in the regulation of the filamentous-growth mitogen-activated protein kinase pathway.

Authors:  Hema Adhikari; Paul J Cullen
Journal:  Eukaryot Cell       Date:  2015-02-27

4.  Candida albicans Biofilm Development and Its Genetic Control.

Authors:  Jigar V Desai; Aaron P Mitchell
Journal:  Microbiol Spectr       Date:  2015-06

Review 5.  Thriving within the host: Candida spp. interactions with phagocytic cells.

Authors:  Pedro Miramón; Lydia Kasper; Bernhard Hube
Journal:  Med Microbiol Immunol       Date:  2013-01-25       Impact factor: 3.402

Review 6.  Fungal biofilms, drug resistance, and recurrent infection.

Authors:  Jigar V Desai; Aaron P Mitchell; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

7.  The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.

Authors:  Aliz Bozó; Marianna Domán; László Majoros; Gábor Kardos; István Varga; Renátó Kovács
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

Review 8.  Interactions of microorganisms with host mucins: a focus on Candida albicans.

Authors:  Ashley Valle Arevalo; Clarissa J Nobile
Journal:  FEMS Microbiol Rev       Date:  2020-09-01       Impact factor: 16.408

9.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

10.  Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Authors:  Eric F Kong; Christina Tsui; Heather Boyce; Ahmed Ibrahim; Stephen W Hoag; Amy J Karlsson; Timothy F Meiller; Mary Ann Jabra-Rizk
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.